{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:48:17Z","timestamp":1791236897345,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82303095"],"award-info":[{"award-number":["82303095"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Special Funding for Postdoctoral Research Project of Chongqing","award":["CSTB2023NSCQ-BHX0024"],"award-info":[{"award-number":["CSTB2023NSCQ-BHX0024"]}]},{"name":"the Special Professorship Project of Chongqing Medical","award":["2021-215"],"award-info":[{"award-number":["2021-215"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Biol"],"DOI":"10.1186\/s13059-026-03982-7","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T12:24:23Z","timestamp":1770639863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ubiquitination degradation of GATA4 by CUL4B promotes ovarian cancer metastasis by inducing lysosomal acidification"],"prefix":"10.1186","volume":"27","author":[{"given":"Xin","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuxiu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"3982_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3773","volume":"371","author":"L Kuroki","year":"2020","unstructured":"Kuroki L, Guntupalli SR. Treatment of epithelial ovarian cancer. BMJ. 2020;371:m3773.","journal-title":"BMJ"},{"key":"3982_CR2","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet. 2019;393:1240\u201353.","journal-title":"Lancet"},{"key":"3982_CR3","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.tig.2017.08.004","volume":"33","author":"N Skrypek","year":"2017","unstructured":"Skrypek N, Goossens S, De Smedt E, Vandamme N, Berx G. Epithelial-to-mesenchymal transition: epigenetic reprogramming driving cellular plasticity. Trends Genet. 2017;33:943\u201359.","journal-title":"Trends Genet"},{"key":"3982_CR4","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1158\/0008-5472.CAN-21-4370","volume":"82","author":"RDZ Mullins","year":"2022","unstructured":"Mullins RDZ, Pal A, Barrett TF, Heft Neal ME, Puram SV. Epithelial-mesenchymal plasticity in tumor immune evasion. Cancer Res. 2022;82:2329\u201343.","journal-title":"Cancer Res"},{"key":"3982_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2022.101086","volume":"88","author":"F Lecaille","year":"2022","unstructured":"Lecaille F, Chazeirat T, Saidi A, Lalmanach G. Cathepsin v: molecular characteristics and significance in health and disease. Mol Aspects Med. 2022;88:101086.","journal-title":"Mol Aspects Med"},{"key":"3982_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nrc1949","volume":"6","author":"MM Mohamed","year":"2006","unstructured":"Mohamed MM, Sloane BF. Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer. 2006;6:764\u201375.","journal-title":"Nat Rev Cancer"},{"key":"3982_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/j.seminoncol.2017.10.013","volume":"44","author":"F Alessandrini","year":"2017","unstructured":"Alessandrini F, Pezz\u00e8 L, Ciribilli Y. LAMPs: shedding light on cancer biology. Semin Oncol. 2017;44:239\u201353.","journal-title":"Semin Oncol"},{"key":"3982_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1074\/mcp.M112.019521","volume":"12","author":"MA Marzinke","year":"2013","unstructured":"Marzinke MA, Choi CH, Chen L, Shih IM, Chan DW, Zhang H. Proteomic analysis of temporally stimulated ovarian cancer cells for biomarker discovery. Mol Cell Proteomics. 2013;12:356\u201368.","journal-title":"Mol Cell Proteomics"},{"key":"3982_CR9","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1158\/1535-7163.MCT-05-0102","volume":"4","author":"R Safaei","year":"2005","unstructured":"Safaei R, Larson BJ, Cheng TC, Gibson MA, Otani S, Naerdemann W, et al. Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther. 2005;4:1595\u2013604.","journal-title":"Mol Cancer Ther"},{"key":"3982_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5907","volume":"5","author":"A He","year":"2014","unstructured":"He A, Gu F, Hu Y, Ma Q, Ye LY, Akiyama JA, et al. Dynamic GATA4 enhancers shape the chromatin landscape central to heart development and disease. Nat Commun. 2014;5:4907.","journal-title":"Nat Commun"},{"key":"3982_CR11","doi-asserted-by":"publisher","first-page":"7460","DOI":"10.1128\/MCB.21.21.7460-7469.2001","volume":"21","author":"Q Liang","year":"2001","unstructured":"Liang Q, Wiese RJ, Bueno OF, Dai YS, Markham BE, Molkentin JD. The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes. Mol Cell Biol. 2001;21:7460\u20139.","journal-title":"Mol Cell Biol"},{"key":"3982_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4680","volume":"5","author":"S Stefanovic","year":"2014","unstructured":"Stefanovic S, Barnett P, van Duijvenboden K, Weber D, Gessler M, Christoffels VM. GATA-dependent regulatory switches establish atrioventricular canal specificity during heart development. Nat Commun. 2014;5:3680.","journal-title":"Nat Commun"},{"key":"3982_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09295-7","volume":"10","author":"L Gao","year":"2019","unstructured":"Gao L, Hu Y, Tian Y, Fan Z, Wang K, Li H, et al. Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition. Nat Commun. 2019;10:1665.","journal-title":"Nat Commun"},{"key":"3982_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27731-5","volume":"13","author":"RS Patel","year":"2022","unstructured":"Patel RS, Romero R, Watson EV, Liang AC, Burger M, Westcott PMK, et al. A GATA4-regulated secretory program suppresses tumors through recruitment of cytotoxic CD8 T cells. Nat Commun. 2022;13:256.","journal-title":"Nat Commun"},{"key":"3982_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-01879-w","volume":"40","author":"W Su","year":"2021","unstructured":"Su W, Zhu S, Chen K, Yang H, Tian M, Fu Q, et al. Overexpressed WDR3 induces the activation of Hippo pathway by interacting with GATA4 in pancreatic cancer. J Exp Clin Cancer Res. 2021;40:88.","journal-title":"J Exp Clin Cancer Res"},{"key":"3982_CR16","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1038\/s41388-022-02521-5","volume":"41","author":"YL Song","year":"2022","unstructured":"Song YL, Yang MH, Zhang S, Wang H, Kai KL, Yao CX, et al. A GRIP-1-EZH2 switch binding to GATA-4 is linked to the genesis of rhabdomyosarcoma through miR-29a. Oncogene. 2022;41:5223\u201337.","journal-title":"Oncogene"},{"key":"3982_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03590-5","volume":"9","author":"D Liu","year":"2018","unstructured":"Liu D, Zhang XX, Li MC, Cao CH, Wan DY, Xi BX, et al. C\/EBP\u03b2 enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation. Nat Commun. 2018;9:1739.","journal-title":"Nat Commun"},{"key":"3982_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006454","volume":"4","author":"KQ Cai","year":"2009","unstructured":"Cai KQ, Caslini C, Capo-chichi CD, Slater C, Smith ER, Wu H, et al. Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia. PLoS One. 2009;4:e6454.","journal-title":"PLoS One"},{"key":"3982_CR19","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1038\/sj.onc.1209533","volume":"25","author":"C Caslini","year":"2006","unstructured":"Caslini C, Capo-chichi CD, Roland IH, Nicolas E, Yeung AT, Xu XX. Histone modifications silence the GATA transcription factor genes in ovarian cancer. Oncogene. 2006;25:5446\u201361.","journal-title":"Oncogene"},{"key":"3982_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ygyno.2022.12.005","volume":"171","author":"G Li","year":"2023","unstructured":"Li G, Xu W, Li X, Chen M, Shi Y, Wei M, et al. Oncogenic SIRT7 inhibits GATA4 transcriptional activity and activates the Wnt signaling pathway in ovarian cancer. Gynecol Oncol. 2023;171:39\u201348.","journal-title":"Gynecol Oncol"},{"key":"3982_CR21","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1038\/s41418-021-00821-z","volume":"28","author":"S Leng","year":"2021","unstructured":"Leng S, Huang W, Chen Y, Yang Y, Feng D, Liu W, et al. SIRT1 coordinates with the CRL4B complex to regulate pancreatic cancer stem cells to promote tumorigenesis. Cell Death Differ. 2021;28:3329\u201343.","journal-title":"Cell Death Differ"},{"key":"3982_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202202737","volume":"10","author":"T Yang","year":"2023","unstructured":"Yang T, Huang W, Ma T, Yin X, Zhang J, Huo M, et al. The PRMT6\/PARP1\/CRL4B complex regulates the circadian clock and promotes breast tumorigenesis. Adv Sci. 2023;10:e2202737.","journal-title":"Adv Sci"},{"key":"3982_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-017-0077-2","volume":"6","author":"Y Li","year":"2017","unstructured":"Li Y, Wang X. The role of cullin4B in human cancers. Exp Hematol Oncol. 2017;6:17.","journal-title":"Exp Hematol Oncol"},{"key":"3982_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-220","volume":"12","author":"A Sarikas","year":"2011","unstructured":"Sarikas A, Hartmann T, Pan ZQ. The cullin protein family. Genome Biol. 2011;12:220.","journal-title":"Genome Biol"},{"key":"3982_CR25","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1038\/s41418-022-01010-2","volume":"29","author":"X Yin","year":"2022","unstructured":"Yin X, Teng X, Ma T, Yang T, Zhang J, Huo M, et al. RUNX2 recruits the NuRD(MTA1)\/CRL4B complex to promote breast cancer progression and bone metastasis. Cell Death Differ. 2022;29:2203\u201317.","journal-title":"Cell Death Differ"},{"key":"3982_CR26","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1158\/0008-5472.CAN-22-3599","volume":"83","author":"J Xu","year":"2023","unstructured":"Xu J, Ye Z, Zhuo Q, Gao H, Qin Y, Lou X, et al. MEN1 degradation induced by neddylation and the CUL4B-DCAF7 axis promotes pancreatic neuroendocrine tumor progression. Cancer Res. 2023;83:2226\u201347.","journal-title":"Cancer Res"},{"key":"3982_CR27","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1093\/nar\/gkv325","volume":"43","author":"J Yi","year":"2015","unstructured":"Yi J, Lu G, Li L, Wang X, Cao L, Lin M, et al. DNA damage-induced activation of CUL4B targets HUWE1 for proteasomal degradation. Nucleic Acids Res. 2015;43:4579\u201390.","journal-title":"Nucleic Acids Res"},{"key":"3982_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202001515","volume":"8","author":"W Huang","year":"2021","unstructured":"Huang W, Zhang J, Huo M, Gao J, Yang T, Yin X, et al. CUL4B promotes breast carcinogenesis by coordinating with transcriptional repressor complexes in response to hypoxia signaling pathway. Adv Sci. 2021;8:2001515.","journal-title":"Adv Sci"},{"key":"3982_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/path.5657","volume":"254","author":"Y Wang","year":"2021","unstructured":"Wang Y, Pan X, Li Y, Wang R, Yang Y, Jiang B, et al. CUL4B renders breast cancer cells tamoxifen-resistant via miR-32-5p\/ER-\u03b136 axis. J Pathol. 2021;254:185\u201398.","journal-title":"J Pathol"},{"key":"3982_CR30","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1038\/s41388-020-1236-1","volume":"39","author":"X Liu","year":"2020","unstructured":"Liu X, Cui J, Gong L, Tian F, Shen Y, Chen L, et al. The CUL4B-miR-372\/373-PIK3CA-AKT axis regulates metastasis in bladder cancer. Oncogene. 2020;39:3588\u2013603.","journal-title":"Oncogene"},{"key":"3982_CR31","first-page":"254","volume":"10","author":"Z Chen","year":"2018","unstructured":"Chen Z, Zhang W, Jiang K, Chen B, Wang K, Lao L, et al. Microrna-300 regulates the ubiquitination of PTEN through the CRL4B(DCAF13) E3 ligase in osteosarcoma cells. Mol Ther. 2018;10:254\u201368.","journal-title":"Mol Ther"},{"key":"3982_CR32","first-page":"94","volume":"25","author":"HR Liu","year":"2021","unstructured":"Liu HR, Zhao J. Effect and mechanism of miR-217 on drug resistance, invasion and metastasis of ovarian cancer cells through a regulatory axis of CUL4B gene silencing\/inhibited Wnt\/\u03b2-catenin signaling pathway activation. Eur Rev Med Pharmacol Sci. 2021;25:94\u2013107.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3982_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-020-00677-w","volume":"13","author":"PJ Duan","year":"2020","unstructured":"Duan PJ, Zhao JH, Xie LL. Cul4B promotes the progression of ovarian cancer by upregulating the expression of CDK2 and cyclinD1. J Ovarian Res. 2020;13:76.","journal-title":"J Ovarian Res"},{"key":"3982_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-020-01701-z","volume":"39","author":"Y Yang","year":"2020","unstructured":"Yang Y, Wang Q, Song D, Zen R, Zhang L, Wang Y, et al. Lysosomal dysfunction and autophagy blockade contribute to autophagy-related cancer suppressing peptide-induced cytotoxic death of cervical cancer cells through the AMPK\/mTOR pathway. J Exp Clin Cancer Res. 2020;39:197.","journal-title":"J Exp Clin Cancer Res"},{"key":"3982_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-01957-z","volume":"40","author":"X Wang","year":"2021","unstructured":"Wang X, Li X, Lin F, Sun H, Lin Y, Wang Z, et al. The lnc-CTSLP8 upregulates CTSL1 as a competitive endogenous RNA and promotes ovarian cancer metastasis. J Exp Clin Cancer Res. 2021;40:151.","journal-title":"J Exp Clin Cancer Res"},{"key":"3982_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.canlet.2019.07.020","volume":"462","author":"SM Soond","year":"2019","unstructured":"Soond SM, Kozhevnikova MV, Frolova AS, Savvateeva LV, Plotnikov EY, Townsend PA, et al. Lost or forgotten: the nuclear cathepsin protein isoforms in cancer. Cancer Lett. 2019;462:43\u201350.","journal-title":"Cancer Lett"},{"key":"3982_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1101\/gad.173930.111","volume":"26","author":"A He","year":"2012","unstructured":"He A, Shen X, Ma Q, Cao J, von Gise A, Zhou P, et al. PRC2 directly methylates GATA4 and represses its transcriptional activity. Genes Dev. 2012;26:37\u201342.","journal-title":"Genes Dev"},{"key":"3982_CR38","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1093\/nar\/gkaa214","volume":"48","author":"L Peng","year":"2020","unstructured":"Peng L, Qian M, Liu Z, Tang X, Sun J, Jiang Y, et al. Deacetylase-independent function of SIRT6 couples GATA4 transcription factor and epigenetic activation against cardiomyocyte apoptosis. Nucleic Acids Res. 2020;48:4992\u20135005.","journal-title":"Nucleic Acids Res"},{"key":"3982_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-023-00440-z","volume":"12","author":"D Luo","year":"2023","unstructured":"Luo D, Chen M, Li Q, Wang K, Wang K, Li J, et al. CUL4B-DDB1-COP1-mediated UTX downregulation promotes colorectal cancer progression. Exp Hematol Oncol. 2023;12:77.","journal-title":"Exp Hematol Oncol"},{"key":"3982_CR40","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2023.2287925","author":"H Heo","year":"2023","unstructured":"Heo H, Park H, Lee MS, Kim J, Kim J, Jung SY, et al. TRIM22 facilitates autophagosome-lysosome fusion by mediating the association of GABARAPs and PLEKHM1. Autophagy. 2023. https:\/\/doi.org\/10.1080\/15548627.2023.2287925.","journal-title":"Autophagy"},{"key":"3982_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102344","volume":"53","author":"W Liu","year":"2022","unstructured":"Liu W, Zhao Y, Wang G, Feng S, Ge X, Ye W, et al. TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS\/AMPK\/mTOR\/autophagy signaling. Redox Biol. 2022;53:102344.","journal-title":"Redox Biol"},{"key":"3982_CR42","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/s41418-019-0458-7","volume":"27","author":"X Wang","year":"2020","unstructured":"Wang X, Xia S, Li H, Wang X, Li C, Chao Y, et al. The deubiquitinase USP10 regulates KLF4 stability and suppresses lung tumorigenesis. Cell Death Differ. 2020;27:1747\u201364.","journal-title":"Cell Death Differ"},{"key":"3982_CR43","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.ccell.2023.03.001","volume":"41","author":"Y Chen","year":"2023","unstructured":"Chen Y, Zhu S, Liu T, Zhang S, Lu J, Fan W, et al. Epithelial cells activate fibroblasts to promote esophageal cancer development. Cancer Cell. 2023;41:903-918.e908.","journal-title":"Cancer Cell"},{"key":"3982_CR44","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.bbrc.2017.01.062","volume":"484","author":"B Wang","year":"2017","unstructured":"Wang B, Shen A, Ouyang X, Zhao G, Du Z, Huo W, et al. Klf4 expression enhances the efficacy of chemotherapy drugs in ovarian cancer cells. Biochem Biophys Res Commun. 2017;484:486\u201392.","journal-title":"Biochem Biophys Res Commun"},{"key":"3982_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1080-5","volume":"18","author":"L Zhang","year":"2019","unstructured":"Zhang L, Zhou Q, Qiu Q, Hou L, Wu M, Li J, et al. CircPLEKHM3 acts as a tumor suppressor through regulation of the miR-9\/BRCA1\/DNAJB6\/KLF4\/AKT1 axis in ovarian cancer. Mol Cancer. 2019;18:144.","journal-title":"Mol Cancer"},{"key":"3982_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05013-x","volume":"9","author":"ST Kundu","year":"2018","unstructured":"Kundu ST, Grzeskowiak CL, Fradette JJ, Gibson LA, Rodriguez LB, Creighton CJ, et al. TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins. Nat Commun. 2018;9:2731.","journal-title":"Nat Commun"},{"key":"3982_CR47","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/s41556-023-01197-7","volume":"25","author":"AP Mutvei","year":"2023","unstructured":"Mutvei AP, Nagiec MJ, Blenis J. Balancing lysosome abundance in health and disease. Nat Cell Biol. 2023;25:1254\u201364.","journal-title":"Nat Cell Biol"},{"key":"3982_CR48","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/15548627.2017.1414126","volume":"14","author":"SY Kim","year":"2018","unstructured":"Kim SY, Kim HJ, Kim HJ, Kim DH, Han JH, Byeon HK, et al. HSPA5 negatively regulates lysosomal activity through ubiquitination of MUL1 in head and neck cancer. Autophagy. 2018;14:385\u2013403.","journal-title":"Autophagy"},{"key":"3982_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202003205","volume":"8","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhou Y, Ma X, Chen L. Inhibition lysosomal degradation of Clusterin by protein kinase D3 promotes triple-negative breast cancer tumor growth. Adv Sci. 2021;8:2003205.","journal-title":"Adv Sci"},{"key":"3982_CR50","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.ccell.2022.08.012","volume":"40","author":"Q Shi","year":"2022","unstructured":"Shi Q, Shen Q, Liu Y, Shi Y, Huang W, Wang X, et al. Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance. Cancer Cell. 2022;40:1207-1222.e1210.","journal-title":"Cancer Cell"},{"key":"3982_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31783-6","volume":"13","author":"B Jiang","year":"2022","unstructured":"Jiang B, Zhao X, Chen W, Diao W, Ding M, Qin H, et al. Lysosomal protein transmembrane 5 promotes lung-specific metastasis by regulating BMPR1A lysosomal degradation. Nat Commun. 2022;13:4141.","journal-title":"Nat Commun"},{"key":"3982_CR52","doi-asserted-by":"crossref","unstructured":"Xin Yin JH. Ubiquitination degradation of GATA4 by CUL4B promotes ovarian cancer metastasis by inducing lysosomal acidification. GSE259274. Gene Expression Omnibus. 2026. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE259274.","DOI":"10.1186\/s13059-026-03982-7"},{"key":"3982_CR53","doi-asserted-by":"crossref","unstructured":"X Yin JH. Ubiquitination degradation of GATA4 by CUL4B promotes ovarian cancer metastasis by inducing lysosomal acidification. GSE260580. Gene Expression Omnibus. 2026. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE260580.","DOI":"10.1186\/s13059-026-03982-7"},{"key":"3982_CR54","unstructured":"Wu R HN, Kuick R, Misek DE, Hanash SM, Zhai Y, Schwartz DR, Akyol A, Katabushi H, Williams BO, Fearon ER, Cho KR. Human ovarian tumors and normal ovaries. GSE6008. Gene Expression Omnibus. 2007. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE6008."},{"key":"3982_CR55","unstructured":"Bowen NJ WL, Matyunina LV, Totten K, Benigno BB, McDonald JF. Ovarian Cancer gene expression profiling identifies the surface of the ovary as a stem cell niche. GSE14407. Gene Expression Omnibus. 2009. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc=GSE14407."},{"key":"3982_CR56","unstructured":"MJ B. Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers. GSE29450. Gene Expression Omnibus. 2011. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi=GSE29450."},{"key":"3982_CR57","unstructured":"Yeung T MS, Wong K. Identification of differentially expressed transcription factors in ovarian cancer. GSE54388. Gene Expression Omnibus. 2017. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc=GSE54388."},{"key":"3982_CR58","unstructured":"Yamamoto Y NG, Mehra K, Tay A, McKeon F, Crum CP, Xian W. Transformation of Human Fallopian Tube Stem Cells and high grade serous ovarian cancer. GSE69428. Gene Expression Omnibus. 2015. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc=GSE69428."},{"key":"3982_CR59","unstructured":"MJ B. A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer. GSE26712. Gene Expression Omnibus. 2011. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE26712."},{"key":"3982_CR60","doi-asserted-by":"publisher","unstructured":"Xin Y JH. Ubiquitination degradation of GATA4 by CUL4B promotes ovarian cancer metastasis by inducing lysosomal acidification. Figshare. 2026. https:\/\/doi.org\/10.6084\/m9.figshare.30946241.","DOI":"10.6084\/m9.figshare.30946241"},{"key":"3982_CR61","doi-asserted-by":"publisher","unstructured":"Xin YJ, He. Ubiquitination degradation of GATA4 by CUL4B promotes ovarian cancer metastasis by inducing lysosomal acidification. Figshare. 2026. https:\/\/doi.org\/10.6084\/m9.figshare.30946211.","DOI":"10.6084\/m9.figshare.30946211"}],"container-title":["Genome Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13059-026-03982-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13059-026-03982-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13059-026-03982-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:03:50Z","timestamp":1773407030000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13059-026-03982-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3982"],"URL":"https:\/\/doi.org\/10.1186\/s13059-026-03982-7","relation":{},"ISSN":["1474-760X"],"issn-type":[{"value":"1474-760X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were approved by the Institutional Animal Care and Use Committee (IACUC-CQMU-0080) and conducted following the Chongqing medical university\u2019s animal policy in accordance with NIH guidelines. Ovarian cancer tissues were collected from three patients diagnosed with ovarian cancer using protocols approved by the Ethics Committee of Chongqing Medical University. The human studies were conducted in accordance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}